Jarislowsky, Fraser LTD Astrazeneca PLC Transaction History
Jarislowsky, Fraser LTD
- $16.1 Billion
- Q3 2024
A detailed history of Jarislowsky, Fraser LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 12,392 shares of AZN stock, worth $813,286. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,392
Previous 14,119
12.23%
Holding current value
$813,286
Previous $1.1 Million
12.35%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,359Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.13 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.76 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.42 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.27 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...